期刊
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
卷 13, 期 -, 页码 -出版社
MATTIOLI 1885
DOI: 10.4084/MJHID.2021.013
关键词
Hematologic malignancies; NGS; Karyotype; FISH
Advanced diagnostic methods such as cytogenetics, molecular cytogenetics, and NGS testing have shown potential importance in identifying genetic abnormalities in myeloid malignancies. Despite conventional techniques being the golden standard, advanced technologies like NGS are highly recommended in cases where cryptic gene fusions or complex abnormalities cannot be easily identified. The study highlighted the detection of novel variations in myeloid malignancies using NGS, with higher pathogenic variation detection rates in certain disease groups.
Advanced diagnostic methods give an advantage for the identification of abnormalities in myeloid malignancies. Various researchers have shown the potential importance of genetic tests before the disease's onset and in remission. Large testing panels prevent false-negative results in myeloid malignancies. However, the critical question is how the results of conventional cytogenetic and molecular cytogenetic techniques can be merged with NGS technologies. In this paper, we drew an algorithm for the evaluation of myeloid malignancies. To evaluate genetic abnormalities, we performed cytogenetics, molecular cytogenetics, and NGS testing in myeloid malignancies. In this study, we analyzed 100 patients admitted to the Medical Genetics Laboratory with different myeloid malignancies. We highlighted the possible diagnostic algorithm for cytogenetically normal cases. We applied NGS 141 gene panel for cytogenetically normal patients, and we detected two or more pathogenic variations in 61 out of 100 patients (61%). NGS's pathogenic variation detection rate varies in disease groups: they were present in 85% of A.M.L. and 23% of M. D.S. Here, we identified 24 novel variations out of total pathogenic variations in myeloid malignancies. A total of 18 novel variations were identified in A.M.L., and 6 novel variations were identified in M.D.S. Despite long turnaround times, conventional techniques are still a golden standard for myeloid malignancies but sometimes cryptic gene fusions or complex abnormalities cannot be easily identified by conventional techniques. In these conditions, advanced technologies like NGS are highly recommended.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据